Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 1, 2002, Pages 38-42

  Alexander, Sarah W ^a   Wade, Kelly C ^a   Hibberd, Patricia L ^a   Parsons, Susan K ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Fever; High risk; Low risk; Neutropenia; Pediatric oncology

Indexed keywords

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CHILD; CHILDHOOD CANCER; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; EVALUATION; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INFECTION; INFECTION RATE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

BOSTON; CHILD; FEMALE; FEVER; HEMATOLOGIC NEOPLASMS; HOSPITALS, PEDIATRIC; HOSPITALS, URBAN; HUMANS; MALE; NEOPLASMS; NEUTROPENIA; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 0036156259     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200201000-00011     Document Type: Article

References (21)

1. Management of fever in patients with cancer and treatment-induced neutropenia
2. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation
3. Approach to treatment of the febrile cancer patient with low-risk neutropenia
4. The outpatient management of febrile neutropenia in cancer patients
5. Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials
6. Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule
7. Comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from the EORTC Studies
8. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
9. Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes
10. Trends in infection morbidity in a pediatric oncology ward, 1986-1995
11. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis
12. Predicting the risk of bacteremia in children with fever and neutropenia
13. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia
14. Early hospital discharge of children with cancer treated for fever and neutropenia: Identification and management of the low-risk patient
15. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia
16. Early discharge of low-risk febrile neutropenic children and adolescents with cancer
17. Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients
18. Double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy
19. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy
20. A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia
21. Home intravenous antibiotic treatment of febrile episodes in immune-compromised pediatric patients